What are the contraindications for Methimazole (antithyroid medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methimazole Contraindications

Absolute Contraindication

The only absolute contraindication to methimazole is hypersensitivity to the drug or any of its components 1.

Critical Clinical Situations Requiring Alternative Therapy

Pregnancy - First Trimester

Methimazole should be avoided during the first trimester of pregnancy due to increased risk of congenital abnormalities 2, 3.

  • Propylthiouracil (PTU) is the preferred antithyroid medication during the first trimester because it carries a lower risk of birth defects compared to methimazole 2, 4.
  • Methimazole-associated birth defects include a specific pattern of rare anomalies: choanal atresia, esophageal atresia, aplasia cutis, and facial abnormalities 4, 5.
  • Switch to methimazole in the second and third trimesters to reduce the risk of PTU-induced hepatotoxicity with prolonged use 2, 3, 4.
  • Women must wait four months after radioactive iodine (I-131) treatment before attempting pregnancy, as I-131 is absolutely contraindicated during pregnancy due to fetal thyroid ablation 2.

Severe Hepatotoxicity or Agranulocytosis

If a patient develops agranulocytosis or severe hepatotoxicity on methimazole, the drug must be permanently discontinued 6, 7.

  • Agranulocytosis occurs in approximately 3 per 10,000 patients and presents with sore throat and fever 6.
  • Both methimazole and PTU can cause hepatitis, vasculitis, and thrombocytopenia in less than 5% of cases 6.
  • Desensitization to methimazole is NOT an option for patients who experienced agranulocytosis or hepatotoxicity 7.
  • For patients with these serious adverse effects, definitive therapy (radioactive iodine or thyroidectomy) should be considered 2, 6.

Relative Contraindications and Special Considerations

Minor Allergic Reactions

  • For patients experiencing rash or pruritus (without agranulocytosis or hepatotoxicity), switching to PTU is one option 7.
  • Alternatively, desensitization to methimazole under allergist supervision is feasible for continued medical therapy or as a bridge to definitive treatment 7.

Breastfeeding

  • While not an absolute contraindication, women must wait four months after I-131 treatment before breastfeeding 2.
  • Methimazole can be used during breastfeeding with appropriate monitoring, though this requires careful consideration 2.

Common Pitfalls to Avoid

  • Do not continue methimazole in the first trimester if pregnancy is confirmed—switch immediately to PTU 2, 3.
  • Do not attempt desensitization in patients with prior agranulocytosis or hepatotoxicity—these are permanent contraindications requiring alternative therapy 7.
  • Do not use radioactive iodine during pregnancy or within four months of planned conception—this causes irreversible fetal thyroid damage 2.
  • Inadequately treated hyperthyroidism increases risks of preeclampsia, preterm delivery, heart failure, and miscarriage, so maintaining thyroid control is essential even when switching medications 2.

References

Guideline

Management of Hyperthyroidism in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Abrupt Switching from Propylthiouracil (PTU) to Methimazole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The safety of methimazole and propylthiouracil in pregnancy: a systematic review.

Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC, 2012

Research

Hyperthyroidism during pregnancy.

Canadian family physician Medecin de famille canadien, 2009

Guideline

Alternative Antithyroid Medications for G-Tube Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Desensitization to Methimazole.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.